Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Don M. Bailey currently holds 75,000 shares of Lineage Cell Therapeutics, Inc. (LCTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Don M. Bailey has been a net seller of LCTX stock. They have purchased $765.3K and sold $106.6M worth of shares.
Don M. Bailey's most recent insider trade was on Jul 1, 2024, when they sold 75,000 shares at $0.00 per share.
Don M. Bailey serves as Executive at Lineage Cell Therapeutics, Inc. (LCTX). They have executed 255 insider transactions totaling $107.3M over their tenure at the company.
Don M. Bailey holds the position of Executive at Lineage Cell Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Don M. Bailey has shown a selling trading pattern, with $765.3K in total purchases and $106.6M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Don M. Bailey was on Sep 8, 2014, when they sold $18.9M worth of MNK shares. This transaction involved 221,177 shares at $85.23 per share.
Don M. Bailey currently owns 75,000 shares of Lineage Cell Therapeutics, Inc. (LCTX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Don M. Bailey's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Don M. Bailey has 255 Form 4 filings on record as an insider at Lineage Cell Therapeutics, Inc..
Set alerts for Don M. Bailey and 40,000+ other insiders.